179 related articles for article (PubMed ID: 36718086)
1. The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment.
Tse N; Parks RM; Holmes HM; Cheung KL
Oncologist; 2023 Mar; 28(3):e128-e135. PubMed ID: 36718086
[TBL] [Abstract][Full Text] [Related]
2. The potential value of comprehensive geriatric assessment in evaluating older women with primary operable breast cancer undergoing surgery or non-operative treatment--a pilot study.
Parks RM; Hall L; Tang SW; Howard P; Lakshmanan R; Winterbottom L; Morgan DA; Porock D; Cox K; Cheung KL
J Geriatr Oncol; 2015 Jan; 6(1):46-51. PubMed ID: 25267539
[TBL] [Abstract][Full Text] [Related]
3. Geriatric assessment tool application in treatment recommendations for older women with breast cancer.
Munir A; Huws A; Khan S; Sharaiha Y; Holt S; Khawaja S
Breast; 2022 Jun; 63():101-107. PubMed ID: 35366503
[TBL] [Abstract][Full Text] [Related]
4. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization due to adverse drug events in older adults with cancer: A retrospective analysis.
Walsh DJ; Sahm LJ; O'Driscoll M; Bolger B; Ameen H; Hannan M; Goggin C; Horgan AM
J Geriatr Oncol; 2023 Jul; 14(6):101540. PubMed ID: 37295287
[TBL] [Abstract][Full Text] [Related]
6. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?
Domínguez-Alonso JA; Conde-Estévez D; Bosch D; Pi-Figueras M; Tusquets I
Clin Transl Oncol; 2021 Jan; 23(1):65-73. PubMed ID: 32449126
[TBL] [Abstract][Full Text] [Related]
8. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study.
Runganga M; Peel NM; Hubbard RE
Clin Interv Aging; 2014; 9():1453-62. PubMed ID: 25214773
[TBL] [Abstract][Full Text] [Related]
9. Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study.
Couderc AL; Boisseranc C; Rey D; Nouguerede E; Greillier L; Barlesi F; Duffaud F; Deville JL; Honoré S; Villani P; Correard F
Clin Interv Aging; 2020; 15():1587-1598. PubMed ID: 32982194
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience.
Gironés R; Torregrosa D; Díaz-Beveridge R
Crit Rev Oncol Hematol; 2010 Mar; 73(3):236-45. PubMed ID: 19748793
[TBL] [Abstract][Full Text] [Related]
11. Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort study.
; ; . PubMed ID: 28236586
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
